Drugs / Acetylsalicyclic acid

Trials 4 · a red edge is where a trial was stopped

200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029203020312032
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07012629 Nov 2025 → Sep 2031 expected MRI defined brain infarct Aarhus University Hospital Recruiting No outcome recorded
Phase 3 NCT01420094 Jun → Sep 2011 Bayer Completed No outcome recorded
Phase 3 NCT01122602 Apr → Jul 2010 Bayer Completed No outcome recorded
Phase 3 NCT00335452 Jun 2006 → Sep 2009 acute coronary syndrome, intermediate coronary syndrome Sanofi Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04142125 Background Feb 2020 → Sep 2023 intracranial arterial disease, ischemic stroke Population Health Research Institute Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Acetylsalicyclic acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT04142125
4

NCT00335452

NCT01122602

NCT07012629

NCT01420094

Known as ASA “Drug: acetylsalicyclic acid (ASA)” NCT00335452
1

“acetylsalicyclic acid (ASA)” NCT07012629

Known as Aspirin “Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)” NCT01122602
Known as BAY1019036 “Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)” NCT01420094
1

“Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)” NCT01122602

Known as BAYE4465 “Acetylsalicyclic acid (Aspirin, BAYE4465)” NCT01122602
Known as Fast acting Aspirin “Acetylsalicyclic acid (Fast acting Aspirin, BAY1019036)” NCT01122602
Known as Fast release Aspirin “Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)” NCT01420094
Route Oral “a single, oral dose of fast release aspirin tablets” NCT01122602